Qingdao Haier Biomedical Co., Ltd. (688139.SH): The actual controller and the concerted action persons collectively increased their holdings by 1.06%.

25/02/2025

GMT Eight

Qingdao Haier Biomedical Co., Ltd. (688139.SH) announced that Qingdao Haichuangzhi Management Consulting Enterprise (Limited Partnership) (referred to as "Haichuangzhi"), a concerted action person of the actual controller Haier Group Corporation, increased its holdings by a total of 3.3731 million shares from January 10, 2025 to February 25, 2025, representing 1.06% of the total shares.

BRONCUS-B (02216) spent 118,000 Hong Kong dollars to repurchase 150,000 shares on February 25th.

Haitong (600837.SH) will delist on March 4th.

Contact: contact@gmteight.com

Qingdao Haier Biomedical Co., Ltd. (688139.SH): The actual controller and the concerted action persons collectively increased their holdings by 1.06%.

RECOMMEND

CSPC PHARMA (01093) issues a profit warning, expecting a decrease of approximately 26% in the annual net profit attributable to shareholders compared to the previous year.

TRADEGO (08017) spent 436,000 Hong Kong dollars to repurchase 1.2 million shares on February 25th.

Shandong Shanda Oumasoft (301185.SZ) wins the bid for the project of scanning teacher qualification examination (NTCE) answer sheets and online scoring technology services.